Optimization of LY545694 tosylate controlled release tablets through pharmacoscintigraphy.

Purpose To optimize a controlled release (CR) matrix formulation with two goals: (1) effectively deliver a prodrug to a preferred absorption region of the upper GI tract, and (2) afford a PK profile similar to a “reference” CR formulation.